HIV Vaccine: Why There Isn’t One Yet, and What Comes Next
There's still no HIV vaccine. See why Mosaico and other big trials failed, what 2025 mRNA germline-targeting studies found and how the PrEP shot differs.
There's still no HIV vaccine. See why Mosaico and other big trials failed, what 2025 mRNA germline-targeting studies found and how the PrEP shot differs.
Zimbabwean researchers and health professionals have been urged to strengthen local research and collaboration to address emerging health challenges affecting people living with HI...
A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections as antibody levels decline, highlighting...
An international study conducted through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, including researchers at the University of Californ...
Learn how a single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.
In the red light district in Mbarara, a city in western Uganda known in part for sex tourism, a sex worker named Lisa Mutoni insists on using condoms when men enter her room, to pr...
Single-nucleus RNA sequencing identifies microglia as the predominant HIV-infected brain cells, offering new insights into persistent viral reservoirs and neurological complication...
FRIDAY, Oct. 9, 2026 — A new long-acting drug combo can restore control over HIV for patients whose virus has developed resistance to commonly used medications, researchers report...
Utafiti mpya wa kisayansi umeibua matumaini katika mapambano dhidi ya Virusi Vya Ukimwi (VVU), baada ya kubaini kuwa kingamwili maalumu zinaweza kuchelewesha kwa kiasi kikubwa kure...
The Trump administration restarted the process for funding four large research networks after postponing it earlier this year.
Harare, Zimbabwe – When Shaun Moyo started nursing at Parirenyatwa Hospital in Harare in the late 1990s, the effects o...
"May be a surprisingly effective route to HIV cure."ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
The networks also develop treatments and preventions for other infectious diseases and were instrumental in testing the Covid vaccine.
The rollout of a groundbreaking drug is an early test in a post-PEPFAR world.
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to...
Antiretroviral therapy has transformed HIV from a fatal diagnosis into a manageable chronic condition, but the benefits of treatment depend entirely on people taking their medicati...
THE experimental M72/AS01 tuberculosis (TB) vaccine has shown a favourable safety profile in people living with HIV who are on antiretroviral therapy (ART), boosting prospects for...
The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensivel...
An injectable HIV drug could save huge numbers of people from getting infected in Uganda.
But shortages of lenacapavir mean that those who need it the most often can't get treate...
MBARARA, Uganda (AP) — In the red light district in Mbarara, a city in western Uganda known in part for sex tourism, a sex worker named Lisa Mutoni insists on using condoms when me...
A clinical trial of anti-PD-1 therapy in men with HIV and cancer demonstrates complex changes in HIV-specific CD8+ T-cell phenotypes and clonal distribution.
Español Infographic text Treatment for HIV is called antiretroviral therapy (ART).ART involves taking a combination of HIV medicines on a regular schedule, called a treatment regi...
A qualitative study of 40 pregnant adolescent refugees aged 15 to 19 living with HIV in Uganda's Nakivale Refugee Settlement found that disclosure was a selective, gradual process,...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.